Medical News

RSS

FDA warning leads to decrease in use of atypical antipsychotics for treatment of dementia

A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Feb 2011

Vatican to host one-day international HIV/AIDS conference in May

The Vatican on Thursday announced it "will host an international conference in May on preventing [HIV/AIDS] and caring for those afflicted with it amid continued confusion over its position concerning condoms as a way to prevent HIV transmission," the Associated Press reports.

8 Feb 2011

Kronos to acquire API Healthcare from Francisco

Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.

8 Feb 2011

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

People who spend more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a study published in the February 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. MS is a chronic disease of the brain and spinal cord, usually with recurrent flare-ups of symptoms. It is often preceded by a first episode (or event) of similar symptoms lasting days to weeks.

8 Feb 2011

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

EpiCept Corporation announced today that it has entered into definitive agreements for the purchase of approximately 8.9 million shares of its common stock at $0.80 per share, and five-year warrants to purchase up to approximately 3.6 million shares of common stock at an exercise price of $0.75 per share.

8 Feb 2011

Employees with strong sense of coherence have more positive response to workplace changes

Employees with a strong sense of coherence—"a stress resistance resource" that is "a key factor in maintaining health"—have a more positive response to workplace changes resulting from a merger, reports a study in the February Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

8 Feb 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

8 Feb 2011

France, FAO call for greater regulation to avert food riots

France, the current chair of the G20, and the U.N. Food and Agriculture Organization (FAO) "warned on Friday about the risk of a new global food crisis and ensuing riots, calling for greater regulation to curb speculation on commodities markets," Reuters reports.

8 Feb 2011

Study identifies genetic variation linked with increased risk of major depression

Numerous studies have shown that the brain molecule neuropeptide Y (NPY) helps to restore calm after stressful events. A team of University of Michigan-led researchers has now found that people whose genes predispose them to produce lower levels of NPY are more responsive to negative stimuli in key brain circuits related to emotion - and are therefore less resilient in the face of stress and may be at higher risk for developing a major depressive disorder.

8 Feb 2011

Misonix completes product registrations in major Latin American countries

Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.

8 Feb 2011

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

8 Feb 2011

U.S. FDA orders three TMJ implant manufacturers to conduct postmarket surveillance studies

Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.

8 Feb 2011

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

JumpStart Ventures, the non-profit that invests in and partners with innovative, early-stage companies in Northeast Ohio, and Cleveland Clinic, announced a combined investment commitment of $500,000 in SironRX Therapeutics, Inc. The Cleveland-based company is developing a topical therapy to enhance healing of and decrease scar formation in wounds.

8 Feb 2011

Anthem Blue Cross reminds seniors in Maine to get vaccinated against annual flu, pneumonia

While the seasonal flu can be very serious for patients of any age, senior citizens are particularly vulnerable. That's why Anthem Blue Cross and Blue Shield in Maine is reminding seniors across the state to get their annual flu and pneumonia vaccinations.

8 Feb 2011

Luminex 2010 revenue increases 17% to $141.6 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2010. Recent

From Luminex 8 Feb 2011

Governors continue to face serious fiscal issues, health programs at risk

The struggle to balance state budgets will involve a long list of cuts - and health programs will be among the items at risk. Meanwhile, a health policy expert explains how state efforts at implementation of the federal health law add to this pressure.

8 Feb 2011

Medical News

FDA warning leads to decrease in use of atypical antipsychotics for treatment of dementia

Vatican to host one-day international HIV/AIDS conference in May

Kronos to acquire API Healthcare from Francisco

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

Employees with strong sense of coherence have more positive response to workplace changes

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

France, FAO call for greater regulation to avert food riots

Study identifies genetic variation linked with increased risk of major depression

Misonix completes product registrations in major Latin American countries

Congress focuses on cognitive treatment for troops with traumatic brain injuries

U.S. FDA orders three TMJ implant manufacturers to conduct postmarket surveillance studies

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Anthem Blue Cross reminds seniors in Maine to get vaccinated against annual flu, pneumonia

Luminex 2010 revenue increases 17% to $141.6 million

Governors continue to face serious fiscal issues, health programs at risk

Schizophrenia patients who consume antipsychotics appear to lose small amount of brain tissue

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Particle Sciences announces strategic alliance with HORIBA Instruments

Breakthrough in Thermal Gradient's fast PCR technology for molecular diagnostics

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News